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Foreword 
The present report aims to provide a comprehensive picture of the pandemic situation of COVID-19 in the 
EU countries, and to be able to foresee the situation in the next coming days. 
We employ an empirical model, verified with the evolution of the number of confirmed cases in previous 
countries where the epidemic is close to conclude, including all provinces of China. The model does not 
pretend to interpret the causes of the evolution of the cases but to permit the evaluation of the quality of 
control measures made in each state and a short-term prediction of trends. Note, however, that the effects 
of the measures’ control that start on a given day are not observed until approximately 7-10 days later. 
 The model and predictions are based on two parameters that are daily fitted to available data: 
 a: the velocity at which spreading specific rate slows down; the higher the value, the better the 
control.  
 K: the final number of expected cumulated cases, which cannot be evaluated at the initial stages 
because growth is still exponential. 
We show an individual report with 8 graphs and a table with the short-term predictions for different 
countries and regions. We are adjusting the model to countries and regions with at least 4 days with more 
than 100 confirmed cases and a current load over 200 cases. The predicted period of a country depends on 
the number of datapoints over this 100 cases threshold, and is of 5 days for those that have reported more 
than 100 cumulated cases for 10 consecutive days or more. For short-term predictions, we assign higher 
weight to last 3 points in the fittings, so that changes are rapidly captured by the model. The whole 
methodology employed in the inform is explained in the last pages of this document. 
In addition to the individual reports, the reader will find an initial dashboard with a brief analysis of the 
situation in EU-EFTA-UK countries, some summary figures and tables as well as long-term predictions for 
some of them, when possible. These long-term predictions are evaluated without different weights to data-
points. We also discuss a specific issue every day.  
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Situation and highlights 
UE+EFTA+UK starts a new week with 
an empiric reproduction number 
slightly above 1. Last days, there are 
appearing several (hopefully) local 
outbreaks all around the continent, 
most of them being properly 
detected and controlled by means of 
the test and trace strategy, but that 
could be reflecting a worrying 
situation in some cases.  
We must recall the usefulness of risk 
diagrams on analysing secondary 
outbreaks: green and yelloy zones 
mean that contagion chains can be 
followed, on average, case by case. 
Red zone implies that test and trace 
is not enough for controlling transmission chains, and that stronger control measures should be considered. 
Then, we see that last days’ increases in new cases in Luxemburg, Croatia, Czech Republic, Romania and 
Bulgaria situate those countries close to or at the yellow zone. Portugal is still stuck at the yellow zone. The 
increase in daily new cases has been controlled, but this value is still not going down again.  Germany could 
be controlling last week outbreaks, since its empirical reproductive number crosses again the control 
thershold (ρ7=0.9). 
Switzerland and Austria, two countries that have been leaders in Europe on controlling the first wave, are 
now showing signs of local outbreaks, but both at the green zone (ρ7 ≈ 2 and 1.3, respectively). Looking at 
the Biocom-Cov scale, which assign a 1 to 9 degree according to the mean daily new cases, both countries 
have increased from level 2 (last week) to 3 (this week). Even Iceland, which remained with 0 or 1 daily new 
case for the last 2 months, is now reporting 3 or 4 daily.  
In all cases, it must be stressed that new cases are not necessarily spread along the country, but that in most 
of countries correspond to local outbreaks, as mentioned. Therefore, in relative terms, the situation in the 
corresponding regions can be really worse.  
Data from Sweden, France and Denmark present some gaps. Therefore, the different indicators and risk 
indexes are not reliable.  
The map in the left shows current A14. The map in the right shows current EPG.         
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(1) ρ7 is the average of 7 consecutive ρ, but can still fluctuate. (2,3) EPG stands for Effective Growth Potential. EPGREP is the product of attack-rate of last 14 days per 105 inhabitants by 
ρ7 (empiric reproduction number). EPGEST is the product of estimated real attack-rate of last 14 days per 105 inhabitants and ρ7. Biocom-Cov degree is an epidemiological situation 
scale based on the level of last week’s mean daily new cases (https://upcommons.upc.edu/handle/2117/189661, https://upcommons.upc.edu/handle/2117/189808). 
 
Situation and trends per country 
Table of current situation in EU countries. Colour scale is relative except when indicated, this means that it is applied independently to each column, and distinguishes 
best (green) form worst (red) situations according to each of the variables. Last column (EPGEST) is assessed with estimated real 14-day attack rate (see report from 
22/04 for details). EPGREP is calculated with data reported by countries. EPGREP and EPGEST cannot be compared between them because scales are different, but can 
be independently used for estimating risk of countries according to reported or estimated real situation, respectively.    
 
Disclaimer: estimated active cases and estimated 14-day attack rate are assessed by assuming a lethality of 1 % (see report from 20 to 24 April, #37-41). This value can change in 




Analysis: An update of the percentage of COVID-19 cases diagnosed in European 
countries. 
The assessment of the percentage of cases diagnosed in a country is important so that the real magnitude of 
the epidemic can be inferred. Our group developed a methodology for determining this percentage1, based 
on the assumption of a 1% lethality and taking into account the delays between onset of symptoms, 
diagnosis, recording, and death (if so).  
In our Report #40(2), we analyzed the evolution of the diagnostic rate in several European countries. During 
the first stages of the epidemic, the diagnostic rate remained quite constant in many countries. Therefore, 
we used to analyze globally the cumulative cases and cumulative deaths in the process of estimating these 
percentages. Nevertheless, the general improvement of the epidemic situation and the possibility of 
implementing test and trace strategies have increased the diagnosis capacity in several countries. Today, we 
present an updated evaluation of the percentage of cases diagnosed with a slight change in the 
methodology: we assess the diagnostic percentage at a certain date by looking at the reported cases and 
deaths of the last month. 
This modification of the methodology entails a consequence: we cannot properly evaluate the diagnosis 
delay because these short data series do not include enough points. Therefore, we assume a mean delay in 
diagnosis of 7 days (i.e., mean delay between diagnosis and death, if so, of 11 days). Then, the percentage of 






𝑑𝑑𝑙𝑙𝑑𝑑𝑙𝑙ℎ𝑑𝑑(𝑙𝑙) − 𝑑𝑑𝑙𝑙𝑑𝑑𝑙𝑙ℎ𝑑𝑑(𝑙𝑙 − 30)
𝑐𝑐𝑑𝑑𝑑𝑑𝑙𝑙𝑑𝑑(𝑙𝑙 − 11) − 𝑐𝑐𝑑𝑑𝑑𝑑𝑙𝑙𝑑𝑑(𝑙𝑙 − 30 − 11)
 
As seen, the lethality is still fixed at 1%. This value should be revised next month, as soon as the results of 
generalized serological screenings are analyzed. In some countries, it seems that mortality could have been 
reduced. Actually, in our general assessments, we consider that low penetration of the virus leads to a lower 
lethality, as it has been observed in the evolution of the CFR in South Korea. We estimate that low activity of 
the virus in Europe could lead to a lethality around 0.7%. This observation could be related with the fact that 
the percentage of young people among confirmed cases has increased, and this collective shows much less 
mortality. Nevertheless, and given that no conclusive results are still available, we have kept the same 
hypotheses as last months.  
The next table shows the diagnostic rate (DR) in European countries on 29th March, 29th April, 29th May, 
and 29th June, as well as the increasing or decreasing trend when comparing two consecutive months and 
the overall trend. We have discarded some countries when we observed either a strong inconsistency in the 
death data series (e.g., a significant decrease in cumulative deaths at some point) or a too low value of 
cumulative deaths (i.e., low reliability of evaluation). 
 






We see that the general trend is an increase in the diagnostic rate. Overall, EU+EFTA+UK countries have 
shift from an initial percentage below 5% up to a 14%. Highest increase would correspond to Portugal, whose 
DR has increased from an initial 4% to a current 40 %. Poland has followed a similar trend (9% to 30%), as 
well as Netherlands (3% to 21%) and Denmark (22% to 36%). Countries like Austria and Germany have 
maintained the initial high DR, at the level of 20%.  
Next, we present a set of figures showing the whole evolution of the diagnostic rate for these countries. 
Shadowed areas represent the degree of uncertainty, which is determined by applying a binomial to the 1% 
lethality (i.e., the probability of dying is a binomial with probability 0.01). The results of Belgium have to be 
considered with caution, since this country reports both confirmed and suspicious deaths by Covid-19, while 
most of the countries only report deaths with a confirmation. Therefore, the Belgian diagnostic rate is 
underestimated. The final figures show the global diagnostic rate for the EU+EFTA+UK countries.  
 
  











Austria 17% 28% 11% 16% -12% 21% 5% 4%
Belgium 3% 5% 2% 9% 4% 13% 4% 10%
Bulgaria 12% 13% 2% 18% 5% 15% -4% 3%
Denmark 22% 15% -6% 28% 12% 36% 8% 14%
France 3% 5% 1% 7% 2% 13% 6% 9%
Germany 19% 23% 4% 17% -7% 23% 6% 4%
Greece 11% 18% 7% 15% -3% 19% 4% 8%
Hungary 3% 6% 3% 8% 2% 8% 0% 5%
Ireland 10% 12% 2% 19% 7% 14% -5% 4%
Italy 3% 8% 5% 9% 1% 8% -1% 5%
Netherlands 3% 7% 4% 11% 4% 21% 11% 19%
Poland 9% 14% 5% 21% 6% 30% 9% 21%
Portugal 4% 21% 17% 25% 4% 40% 15% 35%
Romania 8% 12% 4% 15% 3% 15% 0% 7%
Sweden 16% 5% -11% 9% 4% 21% 12% 5%
Switzerland 12% 21% 9% 14% -7% 18% 4% 6%
United Kingdom 1% 4% 3% 10% 6% 10% 0% 9%
















(1) ρ7 is the average of 7 consecutive ρ, but can still fluctuate. (2,3) EPG stands for Effective Growth Potential. EPGREP is the product of attack-rate of last 14 days per 105 inhabitants by 
ρ7 (empiric reproduction number). EPGEST is the product of estimated real attack-rate of last 14 days per 105 inhabitants and ρ7. Biocom-Cov degree is an epidemiological situation 
scale based on the level of last week’s mean daily new cases (https://upcommons.upc.edu/handle/2117/189661, https://upcommons.upc.edu/handle/2117/189808). 
 
Situation and trends in other countries 
Table of current situation in a sample of non-EU countries. Colour scale is relative except when indicated, this means that it is applied independently to each column, 
and distinguishes best (green) form worst (red) situations according to each of the variables. EPGREP and EPGEST cannot be compared between them because scales 
are different, but can be independently used for estimating risk of countries according to reported or estimated real situation, respectively.    
 
Disclaimer: estimated active cases and estimated 14-day attack rate are assessed by assuming a lethality of 1 % (see report from 20 to 24 April, #37-41). This value can change in 




Time indicators by country 
These tables summarize a few time indicators for each country: time since 50 cases were reported, time 
interval between an attack rate of 1/105 inhabitants and an attack rate of 10/105 inhabitants, and time 






















Evaluated with the whole historical series. Up-left: Predictions of maximum incidences per country at the 
end of the first wave (total final expected attack rate per 105 inh.). Up-right: Predictions of maximum 
absolute number of cases per country at the end of the first wave (K, in log scale). Blue lines indicate current 
situation. Bottom-left: Time in which peak in new cases was achieved / will be achieved. Bottom-right: Time 
at which 90 % of K was achieved / will be achieved. Blue dotted line indicates current date.  
 
Final expected value for EU+EFTA+UK as a whole is not shown any more, since we are in the tail (see 










Situation and trends in Italian and Spanish regions 
Italy 
Data from 26th June, 
 
Spain  
Data from 23rd June, series built with the day of symptoms’ onset 
 
Disclaimer: estimated active cases and estimated 14-day attack rate are assessed by assuming a lethality of 1 % (see 
report from 20 to 24 April, #37-41). This value can change in countries where suspicious deaths are reported as well 
(real values would be lower) and in countries where incidence among elderly people was minor (real values would be 
higher).  
 (1) ρ7 is the average of 7 consecutive ρ, but can still fluctuate. (2,3) EPG stands for Effective Growth Potential. EPGREP is the 
product of attack-rate of last 14 days per 105 inhabitants by ρ7 (empiric reproduction number). EPGEST is the product of 
estimated real attack-rate of last 14 days per 105 inhabitants and ρ7. Biocom-Cov degree is an epidemiological situation 
scale based on the level of last week’s mean daily new cases (https://upcommons.upc.edu/handle/2117/189661, 
https://upcommons.upc.edu/handle/2117/189808). 
 
Long-term predictions are not shown any more, since all Italian and Spanish regions are already in the tail 





Legend: Countries’ reports details 
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Data obtained from  https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases  
 


































































Data obtained from https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases  
 
(2) Analysis and prediction of COVID-19 












































Data updated on 29th June, data series built 
with the day of the symptoms’ onset, reliable 










Data obtained from https://github.com/datadista/datasets/tree/master/COVID%2019 and 
https://covid19.isciii.es/  
 
(3) Analysis and prediction of COVID-19 
























































(1) Data source 
Data are daily obtained from World Health Organization (WHO) surveillance reports3, from European Centre 
for Disease Prevention and Control (ECDC)4 and from Ministerio de Sanidad5. These reports are converted 
into text files that can be processed for subsequent analysis. Daily data comprise, among others: total 
confirmed cases, total confirmed new cases, total deaths, total new deaths. It must be considered that the 
report is always providing data from previous day. In the document we use the date at which the datapoint 
is assumed to belong, i.e., report from 15/03/2020 is giving data from 14/03/2020, the latter being used in 
the subsequent analysis.  
(2) Data processing and plotting 
Data are initially processed with Matlab in order to update timeseries, i.e., last datapoints are added to 
historical sequences. These timeseries are plotted for EU individual countries and for the UE as a whole: 
 Number of cumulated confirmed cases, in blue dots 
 Number of reported new cases 
 Number of cumulated deaths  
Then, two indicators are calculated and plotted, too: 
 Number of cumulated deaths divided by the number of cumulated confirmed cases, and reported as 
a percentage; it is an indirect indicator of the diagnostic level. 
 ρ: this variable is related with the reproduction number, i.e., with the number of new infections 
caused by a single case. It is evaluated as follows for the day before last report (t-1): 
𝜌𝜌(𝑙𝑙 − 1) =
𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑙𝑙) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑙𝑙 − 1) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑙𝑙 − 2)
𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑙𝑙 − 5) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑙𝑙 − 6) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑙𝑙 − 7)
 
where Nnew(t) is the number of new confirmed cases at day t.  
(3) Classification of countries according to their status in the epidemic cycle 
The evolution of confirmed cases shows a biphasic behaviour:  
(I) an initial period where most of the cases are imported; 
(II) a subsequent period where most of new cases occur because of local transmission.  
Once in the stage II, mathematical models can be used to track evolutions and predict tendencies. Focusing 
on countries that are on stage II, we classify them in three groups: 
• Group A: countries that have reported more than 100 cumulated cases for 10 consecutive days or 
more; 
• Group B: countries that have reported more than 100 cumulated cases for 7 to 9 consecutive days; 
• Group C: countries that have reported more than 100 cumulated cases for 4 to 6 days. 
 








(4) Fitting a mathematical model to data 
Previous studies have shown that Gompertz model6 correctly describes the Covid-19 epidemic in all analysed 
countries. It is an empirical model that starts with an exponential growth but that gradually decreases its 
specific growth rate. Therefore, it is adequate for describing an epidemic that is characterized by an initial 
exponential growth but a progressive decrease in spreading velocity provided that appropriate control 
measures are applied.   
Gompertz model is described by the equation:  





where N(t) is the cumulated number of confirmed cases at t (in days), and N0 is the number of cumulated 
cases the day at day t0. The model has two parameters: 
 a is the velocity at which specific spreading rate is slowing down; 
 K is the expected final number of cumulated cases at the end of the epidemic. 
This model is fitted to reported cumulated cases of the UE and of countries in stage II that accomplish two 
criteria: 4 or more consecutive days with more than 100 cumulated cases, and at least one datapoint over 
200 cases. Day t0 is chosen as that one at which N(t) overpasses 100 cases. If more than 15 datapoints that 
accomplish the stated criteria are available, only the last 15 points are used. The fitting is done using Matlab’s 
Curve Fitting package with Nonlinear Least Squares method, which also provides confidence intervals of 
fitted parameters (a and K) and the R2 of the fitting. At the initial stages the dynamics is exponential and K 
cannot be correctly evaluated. In fact, at this stage the most relevant parameter is a. Fitted curves are 
incorporated to plots of cumulative reported cases with a dashed line. Once a new fitting is done, two plots 
are added to the country report: 
 Evolution of fitted a with its error bars, i.e., values obtained on the fitting each day that the analysis 
has been carried out;  
 Evolution of fitted K with its error bars, i.e., values obtained on the fitting each day that the analysis 
has been carried out; if lower error bar indicates a value that is lower than current number of cases, 
the error bar is truncated. 
These plots illustrate the increase in fittings’ confidence, as fitted values progressively stabilize around a 
certain value and error bars get smaller when the number of datapoints increases. In fact, in the case of 
countries, they are discarded and set as “Not enough data” if a>0.2 day-1, if K>106 or if the error in K 
overpasses 106. 
It is worth to mention that the simplicity of this model and the lack of previous assumptions about the Covid-
19 behaviour make it appropriate for universal use, i.e., it can be fitted to any country independently of its 
socioeconomic context and control strategy. Then, the model is capable of quantifying the observed 
dynamics in an objective and standard manner and predicting short-term tendencies.  
(5) Using the model for predicting short-term tendencies 
The model is finally used for a short-term prediction of the evolution of the cumulated number of cases. The 
predictions increase their reliability with the number of datapoints used in the fitting. Therefore, we consider 
three levels of prediction, depending on the country: 
                                                          




• Group A: prediction of expected cumulated cases for the following 3-5 days7; 
• Group B: prediction of expected cumulated cases for the following 2 days; 
• Group C: prediction of expected cumulated cases for the following day. 
The confidence interval of predictions is assessed with the Matlab function predint, with a 99% confidence 
level. These predictions are shown in the plots as red dots with corresponding error bars, and also gathered 
in the attached table. For series longer than 9 timepoints, last 3 points are weighted in the fitting so that 
changes in tendencies are well captured by the model. 
(6) Estimating non-diagnosed cases 
Lethality of Covid-19 has been estimated at around 1 % for Republic of Korea and the Diamond Princess 
cruise. Besides, median duration of viral shedding after Covid-19 onset has been estimated at 18.5 days for 
non-survivors8 in a retrospective study in Wuhan. These data allow for an estimation of total number of 
cases, considering that the number of deaths at certain moment should be about 1 % of total cases 18.5 days 
before. This is valid for estimating cases of countries at stage II, since in stage I the deaths would be mostly 
due to the incidence at the country from which they were imported. We establish a threshold of 50 reported 
cases before starting this estimation.  
Reported deaths are passed through a moving average filter of 5 points in order to smooth tendencies. Then, 
the corresponding number of cases is found assuming the 1 % lethality. Finally, these cases are distributed 
between 18 and 19 days before each one.  
 
                                                          
7 At this moment we are testing predictions at 4 days for countries with more than 100 cumulated cases for 13-15 
consecutive days, and 5 days for 16 or more days.  
8 Zhou et al., 2020. Clinical course and risk factors for mortality of adult 
inpatients with COVID-19 in Wuhan, China: a retrospective 
cohort study. The Lancet; March 9, doi: 10.1016/S0140-6736(20)30566-3 
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